Cargando…
Regional industrial growth and biopharma patent networks: empirical insights from the UK
The COVID-19 pandemic has once again brought the significance of biopharmaceutical and medical technology sectors to the spotlight. Seeing that some of the most critical medical breakthroughs such as the speedy mRNA vaccine development were results of cross-border patenting collaboration, we have pr...
Autores principales: | Gao, Yuan, Zhu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667447/ https://www.ncbi.nlm.nih.gov/pubmed/36408458 http://dx.doi.org/10.1007/s41109-022-00518-3 |
Ejemplares similares
-
Outsourcing Biopharma R to India
por: Chowdhury, P
Publicado: (2011) -
The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy
por: Löfgren, Hans
Publicado: (2007) -
Value drivers of development stage biopharma companies
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022) -
Recepta biopharma portfolio: clinical and pre clinical development
por: Tuma, M Carolina
Publicado: (2014) -
Strategic aspects of higher education reform to cultivate specialists in diagnostic and biopharma industry as applicable to Predictive, Preventive and Personalized Medicine as the Medicine of the Future
por: Studneva, М., et al.
Publicado: (2015)